Answers are grounded in this paper and cite their sources.
Teichomycin A2 was evaluated in vitro against clinical isolates, and its activity was compared with that of other antibiotics. This compound was very active against all organisms tested; its activity was comparable to that of vancomycin, and it was superior to several other antibiotics when tested against gram-positive cocci. Because of its in vitro activity, it deserves clinical evaluation.
No takes yet. Share an insight, caveat, or question.
Fainstein et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: